PTEN and non-small cell lung carcinoma: By siRNA-mediated EPHA7 silencing, Li et al. managed to inhibit NSCLC cell proliferation, migration, and invasion; enhance B-cell lymphoma 2 (Bcl-2) -associated X protein, caspase-3, and phosphatase and tensin homolog (PTEN) expression levels; as well as downregulate phosphorylated-AKT levels [71].